HRT Financial’s Takeda Pharmaceutical TAK Stock Holding History

HRT Financial’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.47M	Buy	278,706 +152,632	+121%	+$2.53M	0.01%	1214
2026 Q1	$2.33M	Buy	126,074 +66,993	+113%	+$1.18M	0.01%	1511
2025 Q4	$921K	Buy	59,081 +13,349	+29%	+$191K	﹤0.01%	1774
2025 Q3	$669K	Buy	45,732 +4,959	+12%	+$73.6K	﹤0.01%	1728
2025 Q2	$630K	Buy	40,773 +18,865	+86%	+$279K	﹤0.01%	1500
2025 Q1	$325K	Buy	+21,908	New	+$307K	﹤0.01%	1736
2024 Q2	–	Sell	-23,195	Closed	-$322K	–	3077
2024 Q1	$322K	Buy	+23,195	New	+$337K	﹤0.01%	1515
2023 Q3	–	Sell	-59,627	Closed	-$936K	–	3073
2023 Q2	$936K	Buy	59,627 +24,186	+68%	+$396K	0.01%	992
2023 Q1	$584K	Buy	+35,441	New	+$565K	0.01%	1252
2021 Q2	–	Sell	-78,827	Closed	-$1.44M	–	3509
2021 Q1	$1.44M	Buy	+78,827	New	+$1.42M	0.01%	815
2020 Q4	–	Sell	-21,662	Closed	-$386K	–	2444
2020 Q3	$386K	Buy	+21,662	New	+$394K	0.01%	1010
2019 Q3	–	Sell	-62,807	Closed	-$1.11M	–	1594
2019 Q2	$1.11M	Buy	62,807 +45,407	+261%	+$826K	0.07%	254
2019 Q1	$354K	Buy	+17,400	New	+$350K	0.05%	261

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

HRT Financial's TAK Position: Q2 2026 in Review

HRT Financial increased its Takeda Pharmaceutical (TAK) stake by 121% in Q2 2026, buying an estimated $2.53M and bringing the position to 278,706 shares worth $4.47M. The position accounts for 0.01% of the portfolio, ranked #1214.

HRT Financial first reported a position in TAK in Q1 2019 and has held it in 13 quarters since. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

HRT Financial held 278,706 shares of Takeda Pharmaceutical worth $4.47M as of Q2 2026.
HRT Financial bought 152,632 Takeda Pharmaceutical shares in Q2 2026, an estimated $2.53M.
Takeda Pharmaceutical made up 0.01% of HRT Financial's portfolio in Q2 2026, its #1214 holding.
HRT Financial first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 13 quarters since.
376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.